Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia.

ABSTRACT:

SUBMITTER: Patnaik MM 

PROVIDER: S-EPMC7531999 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature